Health Care & Life Sciences » Pharmaceuticals | Corcept Therapeutics Inc.

Corcept Therapeutics Inc.

Corcept Therapeutics Inc.
Stock Exchange NASDAQ Stock Market
EPS
$0.61
Market Cap
$1.25 B
Shares Outstanding
114.86 M
Public Float
103.46 M

Profile

Address
149 Commonwealth Drive
Menlo Park California 94025
United States
Employees -
Website http://www.corcept.com
Updated 07/08/2019
Corcept Therapeutics, Inc. engages in the development of drugs for the treatment of severe psychiatric, neurological, and metabolic disorders. It focuses on the development of drugs for disorders that are associated with a steroid hormone called cortisol. Its products include korlym and korlym support.

Financials

View All

James N. Wilson
Chairman
Joseph K. Belanoff
President, Chief Executive Officer, Director & MD